These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3097129)

  • 21. Complete variable region sequences of five homologous high affinity anti-digoxin antibodies.
    Panka DJ; Margolies MN
    J Immunol; 1987 Oct; 139(7):2385-91. PubMed ID: 3655367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody diversity versus antibody complementarity.
    Kabat EA
    Pharmacol Rev; 1982 Mar; 34(1):23-38. PubMed ID: 6803258
    [No Abstract]   [Full Text] [Related]  

  • 23. The antibody molecule to common acute lymphocytic leukemia (cALL) antigen used the identical or closely related VH gene segment as that of MOPC-21 immunoglobulin heavy chain.
    Kudo A; Nishimura Y; Watanabe T
    J Immunol; 1985 Jul; 135(1):642-5. PubMed ID: 3158708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG
    J Immunol; 1990 Nov; 145(9):3150. PubMed ID: 2120347
    [No Abstract]   [Full Text] [Related]  

  • 25. Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16.
    Hamada H; Maezawa K; Tsuruo T
    Nucleic Acids Res; 1990 Apr; 18(7):1900. PubMed ID: 2110659
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody diversity. New mechanism revealed.
    Alt FW
    Nature; 1986 Aug 28-Sep 3; 322(6082):772-3. PubMed ID: 3092104
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of diversity of nucleotide and amino acid distributions in the VD and DJ joining regions in Ig heavy chains.
    Hofle M; Linthicum DS; Ioerger T
    Mol Immunol; 2000 Oct; 37(14):827-35. PubMed ID: 11257304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous randomization of antibody CDRs by a synthetic ligase chain reaction strategy.
    Deng SJ; MacKenzie CR; Narang SA
    Nucleic Acids Res; 1993 Sep; 21(18):4418-9. PubMed ID: 8415016
    [No Abstract]   [Full Text] [Related]  

  • 29. Insertions and deletions in hypervariable loops of antibody heavy chains contribute to molecular diversity.
    Ohlin M; Borrebaeck CA
    Mol Immunol; 1998 Mar; 35(4):233-8. PubMed ID: 9736339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of antibody diversity before and after immunization.
    Gearhart PJ; Lawler AM; Levy NS; Lebecque SG; Malipiero UV
    Ann N Y Acad Sci; 1988; 546():57-62. PubMed ID: 3150261
    [No Abstract]   [Full Text] [Related]  

  • 31. Rearrangements of DNA mediated by terminal transferase.
    Kunkel TA; Gopinathan KP; Dube DK; Snow ET; Loeb LA
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1867-71. PubMed ID: 2937062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary diversification of germ-line versions of human immunoglobulin genes.
    Rabbitts TH; Bentley DL; Flanagan J
    Ann Immunol (Paris); 1984; 135C(1):175-80. PubMed ID: 6324649
    [No Abstract]   [Full Text] [Related]  

  • 33. Rabbit facts and diversification of VH sequences by gene conversion: comments on "A theory of the ontogeny of the chicken humoral immune system: the consequences of diversification by gene hyperconversion and its extension to rabbit".
    Mage RG
    Res Immunol; 1993; 144(6-7):476-83; discussion 483-6. PubMed ID: 8303069
    [No Abstract]   [Full Text] [Related]  

  • 34. Somatic hypermutation: how many mechanisms diversify V region sequences?
    Maizels N
    Cell; 1995 Oct; 83(1):9-12. PubMed ID: 7553877
    [No Abstract]   [Full Text] [Related]  

  • 35. Programmed development of the antibody repertoire.
    Perlmutter RM
    Curr Top Microbiol Immunol; 1987; 135():95-109. PubMed ID: 3107915
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence that the long murine terminal deoxynucleotidyltransferase isoform plays no role in the control of V(D)J junctional diversity.
    Doyen N; Boulé JB; Rougeon F; Papanicolaou C
    J Immunol; 2004 Jun; 172(11):6764-7. PubMed ID: 15153493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the function of germline-encoded VLVH specificity?
    Vainio O; Lassila O; Toivanen P
    Res Immunol; 1993; 144(6-7):448-9. PubMed ID: 8303063
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype.
    Manheimer-Lory A; Katz JB; Pillinger M; Ghossein C; Smith A; Diamond B
    J Exp Med; 1992 Jul; 176(1):309. PubMed ID: 1613463
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene conversion and the generation of antibody diversity.
    Wysocki LJ; Gefter ML
    Annu Rev Biochem; 1989; 58():509-31. PubMed ID: 2673016
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of N-region diversity in Ig heavy chain transcripts expressed by murine fetal liver cells cultured with IL-7.
    Appasamy PM; DeLeo AB; Weng Y; Kenniston TW; Tang L; Burke MA
    Ann N Y Acad Sci; 1995 Sep; 764():112-5. PubMed ID: 7486508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.